Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06658496 · ClinicalTrials.gov registry record

PDA for Kidneys Study

A clinical trial of Congenital Heart Disease and Patent Ductus Arteriosus, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
45
Enrollment target
1
Study location

NCT06658496 is a study of Congenital Heart Disease and Patent Ductus Arteriosus that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 45 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06658496, a study of Congenital Heart Disease and Patent Ductus Arteriosus, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Interventions

  • DEVICE Near Infrared Spectroscopy

Study Locations (1)

Wisconsin

  • Meriter Hospital, Inc. - Madison

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2024-12-19
Est. Completion 2027-05

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06658496

The ClinicalTrials.gov registry entry for NCT06658496 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (90% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Near Infrared Spectroscopy is the first listed.

NCT06658496 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06658496 about?

NCT06658496 is a clinical study titled "PDA for Kidneys Study". The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the hear...

What is the current status of trial NCT06658496?

This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2024-12-19. Estimated completion is 2027-05.

What conditions does trial NCT06658496 study?

This clinical trial studies the following conditions: Congenital Heart Disease, Patent Ductus Arteriosus.

What interventions are being tested in trial NCT06658496?

The interventions under investigation include: Near Infrared Spectroscopy (DEVICE).

Who is sponsoring clinical trial NCT06658496?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06658496 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.